Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
350
-
Total 13F shares, excl. options
-
155M
-
Shares change
-
+11.2M
-
Total reported value, excl. options
-
$6.22B
-
Value change
-
+$420M
-
Put/Call ratio
-
0.68
-
Number of buys
-
174
-
Number of sells
-
-159
-
Price
-
$40.06
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q3 2024
435 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q3 2024.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 350 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 155M shares
of 159M outstanding shares and own 97.84% of the company stock.
Largest 10 shareholders include FMR LLC (22.5M shares), VANGUARD GROUP INC (15.1M shares), T. Rowe Price Investment Management, Inc. (14.2M shares), BlackRock, Inc. (10.8M shares), WELLINGTON MANAGEMENT GROUP LLP (8.74M shares), Bellevue Group AG (7.87M shares), Capital World Investors (7.83M shares), STATE STREET CORP (4.85M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.21M shares), and Tweedy, Browne Co LLC (3.45M shares).
This table shows the top 350 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.